首页 › 弥漫性大B细胞淋巴瘤 › 北卡罗来纳州 › Durham
Durham NC 弥漫性大B细胞淋巴瘤临床试验
14项针对 弥漫性大B细胞淋巴瘤的研究正在 Durham及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma
招募中3 期
- Duke University Medical Center, Durham
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
招募中2 期
- University of North Carolina Medical Center ( Site 0136), Chapel Hill · 距离 10 英里
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
招募中2 期
- Duke Blood Cancer Center, Durham
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
招募中1/2 期
- University of North Carolina at Chapel Hill/ University of North Carolina Medical Center, Chapel Hill · 距离 10 英里
Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU
招募中观察性研究
- Duke University Medical Center - Division of Hematologic Malignancies, Durham
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
招募中3 期
- Duke Cancer Institute, Durham
DALY II USA/ MB-CART2019.1 for DLBCL
招募中2 期
- Duke University Medical Center - Division of Hematologic Malignancies, Durham
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
招募中1 期
- Duke University Medical Center, Durham
Registry of Older Patients With Cancer
招募中观察性研究
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 距离 10 英里
Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.
招募中1 期
- Duke Univerisity, Durham
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
招募中观察性研究
- Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill · 距离 10 英里
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
招募中1 期
- University of North Carolina, Chapel Hill · 距离 10 英里
A Study of NX-1607 in Adults With Advanced Malignancies
招募中1 期
- University of North Carolina, Chapel Hill · 距离 10 英里
Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T Therapy
招募中2 期
- UNC Lineberger Comprehensive Cancer Center, Chapel Hill · 距离 10 英里
其他城市的 弥漫性大B细胞淋巴瘤试验
- New York City, NY21 项研究
- Baldwin Park, CA19 项研究
- Chicago, IL18 项研究
- Los Angeles, CA17 项研究
- Houston, TX17 项研究
- Boston, MA16 项研究
- Milwaukee, WI16 项研究
- Portland, OR15 项研究
- Philadelphia, PA15 项研究
- Nashville, TN14 项研究
- Dallas, TX13 项研究
- Seattle, WA12 项研究
Durham的其他研究
- 乳腺癌63 项研究
- 癌症（所有类型）59 项研究
- 非小细胞肺癌39 项研究
- 多发性骨髓瘤37 项研究
- 转移性癌症33 项研究
- 急性髓系白血病33 项研究
- 肺癌32 项研究
- 前列腺癌32 项研究
- 结直肠癌28 项研究
- 卵巢癌27 项研究
- 慢性淋巴细胞白血病27 项研究
- 心力衰竭26 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月1日。每项研究自行设定入选标准，由研究团队决定谁能参与。